International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards

Home > Other > International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards > Page 701
International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards Page 701

by International GAAP 2019 (pdf)


  On conversion of a convertible instrument at maturity, IAS 32 requires the entity to

  derecognise the liability component and recognise it as equity. There is no gain or loss

  on conversion at maturity. [IAS 32.AG32].

  Thus, for example, if the bond in Example 43.4 above were converted at maturity, the

  accounting entry required by IAS 32 would be:

  €

  €

  Liability

  2,000,000

  Equity 2,000,000

  The precise allocation of the credit to equity (e.g. as between share capital, additional

  paid-in capital, share premium, other reserves and so on) would be a matter of local

  legislation. In addition, IAS 32 permits the €144,284 originally allocated to the equity

  component in Example 43.4 above to be reallocated within equity. [IAS 32.AG32].

  6.3.2

  Conversion before maturity

  6.3.2.A

  ‘Fixed stated principal’ of a bond

  The consideration given for the issue of equity instruments on conversion of a bond is

  the discharge by the holder of the issuer from the liability to pay any further interest or

  principal payments on the bond. If conversion can take place only at maturity, the

  3546 Chapter 43

  amount of the liability transferred to equity on conversion will always (as in

  Example 43.4 at 6.2 above) be €2,000,000. Hence, the conversion right involves the

  delivery of a fixed number of shares for the waiver of the right to receive a fixed amount

  of cash and so is clearly an equity instrument.

  However, the bond in Example 43.4 allows conversion at some point before the full

  term. Therefore, conversion might occur at the end of year 2, when the carrying value

  of the bonds would have been accreted to only €1,909,944. Hence, the carrying amount

  of the liability that is forgiven on conversion can vary depending on when conversion

  occurs. This begs the question as to whether the conversion right now involves the

  delivery of a fixed number of shares for the waiver of the right to receive a variable

  amount of cash, suggesting that it is no longer an equity instrument.

  It is for this reason, in our view, that IAS 32 defines as an equity instrument one that

  involves the exchange of a fixed number of shares for the ‘fixed stated principal’

  rather than the ‘carrying amount’ of a bond. [IAS 32.22]. In other words, IAS 32 regards

  the ‘fixed stated principal’ of the bond in Example 43.4 as a constant €2,000,000.

  The intention is to clarify that the variation in the carrying amount of the bond

  during its term does not preclude the conversion right from being classified as an

  equity instrument.

  6.3.2.B Accounting

  treatment

  IAS 32 refers to the treatment summarised in 6.3.1 above being applied on conversion

  ‘at maturity’. This begs the question of the treatment required if a holder converts prior

  to maturity (as would have been possible under the terms of the bond in Example 43.4).

  As noted in 6.3.2.A above, IAS 32 concludes that the equity component of the bond is

  an equity instrument on the grounds that it represents the holder’s right to call for a

  fixed number of shares for fixed consideration, in the form of the ‘fixed stated principal’

  of the bond.

  It could be argued that the logical implication of this is that, on a holder’s early

  conversion of the bond in Example 43.4 above, the issuer should immediately recognise

  a finance cost for the difference between the then carrying amount of the liability

  component of the bond and the fixed stated principal of €2,000,000. This would create

  a liability of €2,000,000 immediately before conversion, so as to acknowledge that the

  strike price under the holder’s call option is the waiver of the right to receive a fixed

  stated principal of €2,000,000, rather than whatever the carrying value of the bond

  happens to be at the time.

  However, we take the view, supported by general practice, that all that is required is to

  transfer to equity the carrying value of the liability at the date of conversion, as

  calculated after accrual of finance costs on a continuous basis, rather than at the amount

  shown in the most recently published financial statements. In such a case, the

  consideration for the issue of equity instruments is the release, by the bondholder, of

  the issuer from its liability to make future contractual payments under the bond,

  measured at the net present value of those payments.

  IFRIC 19 (which generally applies to debt for equity swaps) does not apply to the

  conversion of a convertible instrument in accordance with its original terms (see 7 below).

  Financial instruments: Financial liabilities and equity 3547

  6.3.2.C

  Treatment of embedded derivatives on conversion

  IAS 32 does not specifically address the treatment of any separated non-equity

  embedded derivatives outstanding at the time of conversion. The issue of principle is

  that, when a holder exercises its right to convert, it is effectively requiring the issuer to

  issue equity in consideration for the bondholder ceding its rights. These may include

  any right to receive future payments of principal and/or interest or to require early

  repayment of the bond. It seems entirely appropriate that any amounts carried in

  respect of such rights, including those reflected in the carrying amount of separated

  embedded derivatives, should be transferred to equity on conversion.

  Where, however, conversion has the effect of removing an issuer’s right (for example,

  to compel early redemption or conversion), this could be seen as a loss to the issuer

  rather than as consideration given by the holder for an issue of equity. In our view,

  however, the loss of such a right by the issuer on conversion by the holder simply

  represents a reduction in the proceeds received for the issue of equity, and should

  therefore by accounted for as a charge to equity (see also 8.1 below).

  6.3.3

  Early redemption or repurchase

  It is not uncommon for the issuer of a convertible bond to redeem or repurchase it before

  the end of its full term, either through exercise of rights inherent in the bond, such as an

  embedded issuer call option, or through subsequent negotiation with bondholders.

  IAS 32 contains guidance for the accounting treatment of an early redemption or

  repurchase of compound instruments following a tender offer to bondholders

  (see 6.3.3.A below).

  It is not entirely clear whether this guidance applies only to redemption pursuant to a

  subsequent negotiation with bondholders, or whether it also applies where redemption

  occurs through exercise of a right inherent in the original terms of the bond. We

  therefore believe an entity has an accounting policy choice if redemption is based on a

  right inherent in original terms of the bond, such as an embedded issuer call option at

  par that was allocated to the liability component and considered to be clearly and

  closely related to the host contract (see 6.3.3.B below).

  6.3.3.A

  Early repurchase through negotiation with bondholders

  When an entity extinguishes a convertible instrument before maturity through an early

  redemption or repurchase in which the original conversion privileges are unchanged,

&nb
sp; IAS 32 requires the entity to allocate the consideration paid and any transaction costs

  for the repurchase or redemption to the liability and equity components of the

  instrument at the date of the transaction. [IAS 32.AG33].

  It is not entirely clear what is meant by a ‘redemption or repurchase in which the original

  conversion privileges are unchanged’. However, we assume that it is intended to imply

  that the repurchase must occur without modification of the original terms of the

  compound instrument, and at a price representing a fair value for the instrument on its

  original terms. A repurchase based on a modification of the original terms of the

  instrument, or at a price implying a modification of them, should presumably be dealt

  with according to the provisions of IAS 32 for the modification of a compound

  3548 Chapter 43

  instrument (see 6.3.4 below) or those in IFRS 9 for the exchange and modification of

  debt (see Chapter 48 at 6.2).

  The method used for allocating the consideration paid and transaction costs to the

  separate components should be consistent with that used in the original allocation to

  the separate components of the proceeds received by the entity when the convertible

  instrument was issued (see 6.2 above). [IAS 32.AG33].

  The issuer is therefore required to:

  • determine the fair value of the liability component and allocate this part of the

  purchase price to the liability component;

  • allocate the remainder of the purchase price to the equity component; and

  • allocate the transaction costs between the liability and equity component on a pro

  rata basis.

  Once this allocation of the consideration has been made:

  • the difference between the consideration allocated to the liability component and

  the carrying amount of the liability is recognised in profit or loss; and

  • the amount of consideration relating to the equity component is recognised

  in equity. [IAS 32.AG34].

  The treatment of a negotiated repurchase at fair value of a convertible instrument is

  illustrated by Example 43.5 below, which is based on an illustrative example in IAS 32.

  [IAS 32.IE39-46].

  Example 43.5: Early repurchase of convertible instrument

  For simplicity this example:

  • assumes that at inception the face amount of the instrument was equal to the carrying amount of its liability

  and equity components in the financial statements – i.e. there was no premium or discount on issue; and

  • ignores transaction costs and tax.

  On 1 January 2014, an entity issued a convertible bond with a face value of €100 million maturing on

  31 December 2023, at which point the holder may opt for repayment of €100 million or conversion into

  4 million shares. Interest is paid half-yearly in arrears at a nominal annual interest rate of 10% (i.e. €5m per

  half year). At the date of issue, the entity could have issued non-convertible debt with a ten-year term bearing

  interest at 11%. On issue, the carrying amount of the bond was allocated as follows:

  €m

  Present value of the principal – €100m payable at the end of ten years1

  34.3

  Present value of the interest – 20 6-monthly payments of €5m2

  59.7

  Total liability component

  94.0

  Equity component (balance)

  6.0

  Proceeds of the bond issue

  100.0

  The amounts above are discounted using a semi-annual rate of 5.5% (11%÷2) as follows:

  1 €100m/1.05520

  2

  €5m × (1/1.055 +1/1.0552+ 1/1.0553+ ... 1/1.05520)

  On 1 January 2019, the entity makes a tender offer to the holder of the bond to repurchase the bond at its then

  fair value of €170 million, which the holder accepts. At the date of repurchase, the entity could have issued

  non-convertible debt with a five-year term with interest payable half-yearly in arrears at an annual coupon

  interest rate of 8%.

  Financial instruments: Financial liabilities and equity 3549

  At the time of repurchase, the carrying amount of the liability component of the bond, discounted at the

  original semi-annual rate of 5.5% is as follows.

  €m

  Present value of the principal – €100m payable at the end of five years1

  58.5

  Present value of the interest – 10 6-monthly payments of €5m2

  37.7

  Carrying value of liability component

  96.2

  10

  1

  €100m/1.055

  2

  3

  10

  2

  €5m × (1/1.055 +1/1.055 + 1/1.055 + ... 1/1.055 )

  The fair value of the liability component of the bond, discounted at the current semi-annual rate of 4% (8%÷2)

  is as follows.

  €m

  Present value of the principal – €100m payable at the end of five years1

  67.6

  Present value of the interest – 10 6-monthly payments of €5m2

  40.5

  Fair value of liability component

  108.1

  10

  1

  €100m/1.04

  2

  3

  10

  2

  €5m × (1/1.04 +1/1.04 + 1/1.04 + ...1/1.04 )

  The fair value calculation indicates that, of the repurchase price of €170 million, €108.1 million is to be

  treated as redeeming the liability component of the bond, and the balance of €61.9 million as redeeming the

  equity component. This gives rise to the accounting entry:

  €m €m

  Liability component of bond

  96.2

  Equity 61.9

  Debt settlement expense (profit or loss)

  11.9

  Cash

  170.0

  The debt settlement expense represents the difference between the carrying value of the debt component

  (€96.2m) and its fair value (€108.1m).

  Any costs of the repurchase would have been allocated between profit or loss and equity in proportion to the

  fair value of the liability and equity components at the time of redemption.

  6.3.3.B

  Early repurchase through exercising an embedded call option

  It is not entirely clear whether the guidance in 6.3.3.A above applies only on early

  redemption or repurchase to a subsequent negotiation with bondholders, or whether it

  also applies where redemption occurs through exercise of rights inherent in the terms

  of the bond (for example an issuer call option at par allocated to the liability component

  and considered to be clearly and closely related to the host contract).

  One way of accounting for such redemptions would be by applying the accounting

  treatment as discussed under 6.3.3.A above.

  If, however, this early repayment option was determined, on initial recognition of the

  convertible bond, to be clearly and closely related to the liability host contract

  (see 6.4.2.A below), then it might be argued that the general measurement rules of

  IFRS 9 apply. In such a case the liability (including the embedded call option) would be

  measured at amortised cost (assuming that it was not designated at fair value through

  profit or loss on initial recognition). Accounting under the amortised cost method is

  3550 Chapter 43

  based on an effective interest rate, calculated initially based on expected future cash


  flows. Any change in those expected cash flows is reflected in the carrying amount of

  the financial instrument, by computing the present value of the revised estimated future

  cash flows at the instrument’s original effective interest rate, with any difference from

  the previous amortised cost carrying amount recorded in profit or loss. [IFRS 9.B5.4.6].

  A change in the expected repayment date would therefore require the amortised cost of the

  financial liability component to be remeasured. This treatment has the effect that the overall

  repayment amount at par is allocated to the liability portion of the compound instrument.

  6.3.4 Modification

  An entity may amend the terms of a convertible instrument to induce early conversion,

  for example by offering a more favourable conversion ratio or paying other additional

  consideration in the event of conversion before a specified date. The difference, at the

  date the terms are amended, between:

  • the fair value of the consideration the holder receives on conversion of the

  instrument under the revised terms; and

  • the fair value of the consideration the holder would have received under the

  original terms,

  is recognised as a loss in profit or loss. [IAS 32.AG35]. IAS 32 illustrates this treatment, as

  shown in Example 43.6 below. [IAS 32.IE47-50].

  Example 43.6: Modification of the terms of a bond to induce early conversion

  Suppose that the entity in Example 43.5 at 6.3.3.A above wished, on 1 January 2019, to induce the bondholder

  to convert the bond early. The original terms of the bond allowed for conversion into 4 million shares. The

  entity offers the bondholder the right to convert into 5 million shares during the period 1 January to

  28 February 2019. The market value of the entity’s shares is €40 per share.

  The enhanced conversion terms offer the bondholder the right to receive an additional 1 million shares.

  Accordingly, the entity recognises a cost of €40m (1m shares × share price €40/share) in profit or loss.

  6.4

  The components of a compound instrument

 

‹ Prev